从CDO1介导AQP2泛素化/磷酸化“串扰”促进其内吞转移探讨水臌贴“从肾论治肝硬化腹水”的机制
批准号:
82074386
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
祝峻峰
依托单位:
学科分类:
中医内科学
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
祝峻峰
中文摘要
腹水是肝硬化失代偿期最突出的临床症状之一,其迁延难愈、反复发作易肝病及肾,首损肾阳致气不化水,使病情加重而威胁患者生存率。课题组临证以水臌贴消水除胀疗效良好,高通量筛选验证其可能靶向肾脏AQP2;预实验表明桂皮酮(水臌贴主要透皮成分之一)促进肾小管上皮细胞中AQP2内吞转移并复杂翻译后修饰。由此假设:水臌贴治疗肝硬化腹水与其靶向促进肾小管上皮细胞AQP2质膜转移有关;透皮后,其活性成分调控AQP2的泛素化/磷酸化串扰,发挥“温肾化气”作用。本项目拟利用基因敲减、表面等离子共振、GST-tag标签亲和纯化、定点突变等方法,从动物和细胞水平研究水臌贴通过CDO1/AQP2轴治疗肝硬化腹水效果,及透皮后调控AQP2内吞转移和双重修饰间串扰关系的机制,以阐明水臌贴“利水消胀”获效机制和“温肾化气”物质基础,对水臌贴“从肾论治肝硬化腹水”提供理论支持,并促进中医敷贴特色疗法防治肝硬化腹水的临床推广。
英文摘要
Ascites is one of the most prominent clinical symptoms in the decompensated stage of cirrhosis, the repeating and lingering pathological process tend to cause the liver disease affecting the kidney. In the meanwhile, ascites will deteriorate kidney yang causing unhealed ascites and further aggravation, threatening patient’s survival rate. We previously used Shuigu Patch in the treatment of cirrhosis ascites and gained a positive effect. We then analyzed the genomics differences in kidney of cirrhotic ascites rats and found that AQP2 one possible target of Shuigu Patch. Further we proved that Cinnamone, one of the main transdermal components of Shuigu Patch, may promote endocytosis transfer of AQP2 together with ubiquitination and phosphorylation modification in tubular epithelial cells. Therefore, a hypothesis is proposed: the effects of Shuigu Patch on cirrhosis ascites is related to its targeted promotion of AQP2 transfer from plasma to membrane; after the Shuigu Patch’s transdermal application, it interferes CDO1-mediated endocytosis of AQP2 with crosstalk between ubiquitination and phosphorylation, which may play an important role in nouring and warming the kidney thus facilitating diuresis reduction. This project intends to study the effect of Shuigu Patch on cirrhosis ascites and the role CDO1/AQP2 axis in vivo and in vitro. We will employ gene knockdown, surface plasmon resonance technology, GST-tag tag affinity purification, site-directed mutation of genes, etc. to study the complex modification mechanism of AQP2, especially its crosstalk between ubiquitination and phosphorylation. This research will elucidate the molecular mechanism of Shuigu Patch on "diuresis and dilation" and "warming kidney and facilitating qi", and also provide support for cirrhosis ascites treatment based on the kidney function, which is benefit for promoting clinical popularization of TCM application therapy in cirrhosis ascites treatment.
项目背景:.肝硬化腹水作为肝硬化失代偿期的突出临床症状,严重影响患者生存质量。中医理论认为,腹水迁延难愈、反复发作易损伤肾阳,导致气不化水,病情加重。课题组基于临床实践,发现水臌贴在消水除胀方面疗效显著,并推测其可能通过靶向肾脏AQP2发挥作用。本研究旨在深入探究水臌贴治疗肝硬化腹水的机制,特别是其如何通过调控肾小管上皮细胞AQP2的内吞转移及泛素化/磷酸化修饰,实现“温肾化气”的中医理论效应。.主要研究内容:.制备并改良大鼠肝硬化腹水模型,为后续实验提供稳定可靠的动物模型;研究水臌贴对肝硬化腹水大鼠的消胀利水及肝肾保护作用,并鉴定其主要透皮成分;深入探究水臌贴及其主要活性成分对肾小管上皮细胞AQP2的定位、含量及修饰状态的影响;通过基因敲减、表面等离子共振、GST-tag标签亲和纯化、定点突变等技术,从细胞和动物水平揭示水臌贴通过CDO1/AQP2轴治疗肝硬化腹水的机制。.重要结果:.1.成功制备并改良了肝硬化腹水大鼠模型,提高了模型的稳定性。.2.水臌贴显著改善了肝硬化腹水大鼠的肝脏炎症和纤维化,并鉴定了黄芪有效成分毛蕊异黄酮葡萄糖苷和桂皮醛为主要透皮成分。.3.桂皮醛被证实可通过调节肝星状细胞中的Notch3信号传导来改善肝损伤和纤维化。.4.水臌贴及其主要活性成分桂皮醛短期内可调节肾脏上皮细胞中AQP2的定位,长期干预上调AQP2含量,增强肾脏排泄功能。.5.体外实验表明,水臌贴及其活性成分可促进肾小管上皮细胞AQP2的泛素化和磷酸化修饰,深入探讨了其“温肾化气”的作用机制。.关键数据:.肝硬化腹水大鼠模型成模率的提升;水臌贴治疗后,大鼠腹水有明显减少;桂皮醛通过介导CYP2A6来调节肝星状细胞活化中的Notch3信号传导;水臌贴及其主要活性成分CA干预,可以调节AQP2在肾脏上皮上定位,且长期干预上调肾脏中AQP2的含量。.科学意义:.本项目揭示了水臌贴治疗肝硬化腹水的机制,特别是其如何通过调控肾小管上皮细胞AQP2的内吞转移及泛素化/磷酸化修饰来发挥作用。这不仅为中医“从肾论治肝硬化腹水”提供了理论支持,也为中医敷贴特色疗法在肝硬化腹水防治中的临床推广奠定了坚实基础。本研究还鉴定了水臌贴的主要透皮成分,并深入探讨了其活性成分的作作用机制,为中药现代化研究提供了新的思路和方法。研究成果已发表多篇SCI及中文核心期刊论文,具有较高的学术价值和和应用前景。
国内基金
海外基金